Very interesting read. A major problem IMHO is the lack of incentive towards software maintenance in academia... It is unacknowledged work most of the time.

Finally, our SARS-CoV-2 genomes were deposited on GISAID Initiative and picked-up by Nextstrain. We are very thankful for both of those tools. This was a long journey but we are there now and we will update our genome submissions as frequently as possible. \0/

Une analyse des données de fréq du variant B.1.1.7 en FR avec un modèle épidémio montre : avantage de transmission inféré environ +41%, variant deviendrait majoritaire fin-février à début avril selon régions, et causerait une augmentation du nb de cas pour l'instant peu visible

A question we had in the lab finally has an answer !

Impossible not to re-tweet that.

🦠Nos modestes données sur l'utilisation limitée de monothérapie d'anticorps monoclonal chez patients COVID-19 à très haut risque Cela n'a duré que quelques jours avant que nous disposions de cocktails d'anticorps, beaucoup moins à risque d'échappement. mdpi.com/1999-4915/13/8…

Our pilot study on lung microbiome 100% COVID-free. #lungmicrobiome #microbiome #microbiote #microbes #intensivecare Antoine Bridier-Nahmias IAME Research Center Jean-Damien Ricard The 16S rRNA lung microbiome in mechanically ventilated patients: a methodological study tandfonline.com/doi/full/10.10…

#papersofthemonth ASM : "#Azithromycin resistance in Shiga-toxin Producing #Escherichia_coli in France between 2004 and 2020 and detection of mef(C)-mph(G) genes." ClaireAmaris_Hobson Antoine Bridier-Nahmias Weill François-Xavier doi.org/10.1128/AAC.01…

#papersofthemonth Scientific Reports : "#Nosocomial transmission clusters and lineage diversity characterized by #SARSCoV2 genomes from two large hospitals in Paris, France, in 2020 " nature.com/articles/s4159… Antoine Bridier-Nahmias Goldstein Valérie François Blanquart Visseaux Benoit

Very French story...

Phylodynamics of SARS-CoV-2 transmissions in France, Europe and the world during 2020 medrxiv.org/cgi/content/sh… #medRxiv